Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00539_DB01211_nanopub.RA0wW7hVM-LVi4hT0FrAYAUrjfhqaFCV3e0-vpgtRLk5g#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00539_DB01211 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00539_DB01211 label "DDI between Toremifene and Clarithromycin - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration. [drugbank_resource:DB00539_DB01211]" assertion.
- drugbank_resource:DB00539_DB01211 identifier "drugbank_resource:DB00539_DB01211" assertion.
- drugbank_resource:DB00539_DB01211 title "DDI between Toremifene and Clarithromycin - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration." assertion.
- drugbank:DB00539 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB01211 assertion.
- drugbank:DB01211 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB01211 assertion.